Reuters: Money News: Canada drugmaker Valeant to buy Bausch & Lomb for $8.7 billion

Reuters: Money News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.

Canada drugmaker Valeant to buy Bausch & Lomb for $8.7 billion May 28th 2013, 05:07 TORONTO/WINNIPEG, Manitoba (Reuters) - Valeant Pharmaceuticals International said on Monday it agreed to buy Bausch & Lomb Holdings Inc from Warburg Pincus LLC for $8.7 billion, a cash deal set to vault the Canadian company into the upper ranks of the global pharmaceutical sector.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions